Watchlist Price Alert

Twist Bioscience Corporat... (TWST)

NASDAQ: TWST · Real-Time Price · USD

36.02

-3.22 (-8.21%)

At close: May 05, 2025, 3:59 PM

35.51

-1.42%

After-hours: May 05, 2025, 04:14 PM EDT

-8.21% (1D)

Bid	35.5
Market Cap	2.15B
Revenue (ttm)	330.19M
Net Income (ttm)	-197.31M
EPS (ttm)	-3.38
PE Ratio (ttm)	-10.66
Forward PE	-25.22
Analyst	Buy

Ask	36.71
Volume	1,858,068
Avg. Volume (20D)	1,181,438
Open	41.27
Previous Close	39.24
Day's Range	35.25 - 42.07
52-Week Range	33.16 - 60.90
Beta	2.34

About TWST

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration ...

Sector Healthcare

IPO Date Oct 31, 2018

Employees 923

Stock Exchange NASDAQ

Ticker Symbol TWST

Website https://www.twistbioscience.com

Full Company Profile

Analyst Forecast

According to 9 analyst ratings, the average rating for TWST stock is "Buy." The 12-month stock price forecast is $56, which is an increase of 55.47% from the latest price.

Stock Forecasts

Earnings Surprise

New

Twist Bioscience has released their quartely earnings on May 5, 2025:

Revenue of $92.79M exceeds estimates by $753K, with 23.23% YoY growth.

EPS of -0.66 misses estimates by -0.10, with 16.46% YoY growth.

Next Earnings Release

Twist Bioscience Corporation is scheduled to release its earnings on May 5, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 hours ago New

Twist Bioscience shares are trading lower after th... Unlock content with Pro Subscription

5 months ago

+9.87%

Twist Bioscience shares are trading higher after Leerink Partners maintained its Hold rating on the stock.

News

8 hours ago · seekingalpha.com

Twist Bioscience Corporation (TWST) Q2 2025 Earnings Call Transcript

Twist Bioscience Corporation (NASDAQ:TWST ) Q2 2025 Earnings Conference Call April 5, 2025 8:00 AM ET Company Participants Angela Bitting - Senior Vice President of Corporate Affairs Emily Leproust - ...

Just now · zacks.com

Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates

Twist Bioscience (TWST) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.79 per share a year ago.

1 hour ago · businesswire.com

Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...

1 hour ago · businesswire.com

Twist Bioscience Spins Out DNA Data Storage as Independent Company

4 days ago · seekingalpha.com

Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers

Twist Bioscience has shown revenue growth from $54.4m in 2019 to potentially >$300m in 2024, but continues to post losses. Despite a diverse customer base and innovative synthetic DNA technology, Twis...

1 week ago · businesswire.com

Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System.

1 month ago · businesswire.com

Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics

SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...

1 month ago · zacks.com

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Investors interested in the Genomics and Synthetic Biology theme should consider these stocks: Twist Bioscience Corporation, Wave Life Sciences, and CRISPR Therapeutics AG.

1 month ago · zacks.com

Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last?

Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price inc...

1 month ago · businesswire.com

Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost

Load More News